© DZIF/Blitzfang


Here you will find news and press releases of the DZIF as well as our media centre.

Press Office

If you have any questions about DZIF or specific press releases, you have come to the right place. We will also gladly put you on to the experts in each specific field. Please get in touch with us.

Oliver Cornely
© Michael Wodak

Prof. Oliver Cornely receives Johann Lucas Schönlein Plaque from the German-speaking Mycological Society

Prof. Oliver Cornely, infectiologist and coordinator of the DZIF Clinical Trial Unit at the University Hospital Cologne, has been awarded the Johann Lucas Schönlein Plaque by the German-speaking
Left panel: grey electron microscopic image of rod-shaped M. tuberculosis bacteria; right panel: image of a circular phylogenetic tree depicting the genetic relationship between M. tuberculose strains
© S. Homolka, T. Gutsmann/Borstel; CC BY 4.0/Finci, I. et al.

Personalised antibiotic treatment strategies for tuberculosis patients

Tuberculosis is one of the leading causes of death worldwide, with an estimated 1.4 million deaths and ten million people infected annually. Resistant and multidrug-resistant (MDR) variants of the
Namibian mother and daughter, dressed in T-shirts and skirts, the woman additionally wearing a green-brownish-coloured headscarf, squatting in front of a light blue-coloured wall.Eine afrikanische Mutter mit Tocher, beide tragen T-Shirts und Röcke, die Mutter zudem ein grün-schwarz gemustertes gebundenes Kopftuch. Beide hocken vor einer hellblau gesprichenen Wand.
© Christoph Lange

BCG tuberculosis vaccine only effective in early childhood

In the early 20th century, French scientists Albert Calmette and Camille Guérin developed a vaccine from the bovine tuberculosis bacterium Mycobacterium bovis, which was named BCG (Bacillus Calmette

Always up-to-date

Sign up for our quarterly newsletter and our press releases and stay up to date.

Select mailing lists
9 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.



Media Centre